Pharmacogenomic testing is changing how we think about medication. According to this post from the National Human Genome Research Institute (NHGRI), 98% of people have genetic variations that affect how they respond to medications. That’s nearly everyone—yet most prescriptions are still based on broad guidelines rather than individual genetics. Making pharmacogenomic testing more accessible and scalable takes more than great science. It takes the right infrastructure to get test kits where they need to go—and back to the lab—without delays or compliance headaches. That’s where WellPact comes in. We handle the details so your testing program runs smoothly: ✔ Custom-built test kits with the right tracking and labeling for clean lab workflows ✔ Fulfillment and logistics designed to scale with your program ✔ Regulatory-compliant returns so samples arrive intact and on time ✔ Timely data handoff to keep labs moving efficiently 💡 Working on a pharmacogenomic testing program? Let’s connect! We make the logistics simple—so you can focus on the science.
Studies indicate that more than 98% of people have a genomic variant that could affect how they respond to commonly prescribed medications. For example, some people might respond to a standard dose of medication, while others will respond better to a higher or lower dose. Pharmacogenomic testing can determine whether a patient has specific genomic variants that could affect how they respond to a specific medication. The testing involves analyzing the patient’s DNA obtained from a saliva sample, a blood sample or a cheek swab. Based on the results, the healthcare provider can make more informed recommendations for a medication. Scientists have identified over 100 medications for which known genomic variants play an important enough role to inform the guidelines for prescribing those medications. Researchers are continuously identifying new interactions between medications and genomic variants. Learn more about pharmacogenomics in our new fact sheet! https://lnkd.in/e28CszNe